News

Clinical Trials

September 20, 2021

Retina Foundation is Major Center for Next Phase of Gene Therapy for X-Linked Retinitis Pigmentosa: SKYLINE

X-linked retinitis pigmentosa (XLRP) is an inherited eye disease that causes gradual vision loss in boys and young men. The disease begins with night blindness and a progressive loss of peripheral vision. This disease eventually leads to central vision loss and results in a person becoming legally blind in their 40s. The Retina Foundation has […]

READ MORE

Clinical Trials

August 26, 2021

Age-Related Macular Degeneration Happenings at the Foundation

At the Retina Foundation, our Laboratory Directors often partner with various pharmaceutical and biotechnology companies to conduct clinical trials and research. In our Clinical Center of Innovation for Age-Related Macular Degeneration (AMD), led by Karl Csaky, M.D., Ph.D., Chief Executive and Medical Officer of the Foundation, we currently have 15 studies for AMD and geographic […]

READ MORE

Clinical Trials

June 29, 2021

Assessing Mobility Vision and Retinitis Pigmentosa

Scientists in the Rose-Silverthorne Retinal Degeneration Laboratory at the Retina Foundation recently began a new clinical trial utilizing a mobility course. The course is designed to assess mobility and functional vision in patients with retinitis pigmentosa (RP), an inherited eye disease characterized by gradual vision loss of peripheral and night vision. This mobility course, created by […]

READ MORE

Clinical Research

May 21, 2021

Investigating Reading Readiness in Preschool Children with Amblyopia (Lazy Eye)

Previously at the Retina Foundation, we have proven that children with lazy eye read 25% slower than their peers. This may put them at a disadvantage during timed standardized testing. Now, we are investigating WHY children with lazy eye are slow at reading. We are unsure whether the problem begins earlier in life when children […]

READ MORE

News/ Press Release

May 19, 2021

A Fireside Chat with Dr. Anthony S. Fauci

DALLAS, TX (May 19, 2021) – On Thursday, June 3, 2021, Dr. Anthony S. Fauci will join the Retina Foundation of the Southwest, in partnership with the Dallas Regional Chamber, for Up Close and Personal with Dr. Anthony S. Fauci: A Fireside Chat to Discuss Science, Collaborations, and All Things COVID. Dr. Anthony Fauci, alongside […]

READ MORE

News/ Press Release

March 16, 2021

A Year Ago Today

One year ago, the Retina Foundation temporarily closed its doors to help stop the spread of the new coronavirus. Looking back on the past year, we were able to successfully navigate this new challenge, and continue with our mission to prevent vision loss and restore sight through innovative research and treatment. Our research scientists and […]

READ MORE

News/ Press Release

December 20, 2020

Fogg Charitable Trust Awards $50,000 Grant to the Retina Foundation

The Edward C. Fogg, III and Lisbeth A. Fogg Charitable Trust recently awarded a grant of $50,000 to the Retina Foundation in support of research for inherited eye diseases. With this grant, the Retina Foundation plans to upgrade our system for measuring the function of rods and cones in the human eye. Rods and cones […]

READ MORE

Patient Story

December 7, 2020

A Family Forever Changed by Research

Read more about the ways in which Retina Foundation impacts lives in our news section.

READ MORE

Clinical Trials

June 16, 2020

Choroideremia Research Is Necessary to Help Prevent Blindness at an Early Age

Choroideremia is an X-linked, recessive, inherited retinal disorder that affects 1 in 50,000 individuals. X-linked refers to the X chromosome, which is one of the chromosomes that determines gender. Females receive an X chromosome from each parent; therefore, females can be carriers of the disease and asymptomatic if choroidermemia is passed down from only one […]

READ MORE